INDP Indaptus Therapeutics, Inc. stock chart & analysis
Conviction 21LongHealthcareScan · Wed, Nov 4, 2026Indaptus Therapeutics, Inc. (INDP) closed at $3.28 (+1.23%) on Nov 4, 2026. Its chart shows a bull flag pattern. Price is above its 50-day and above its 200-day moving average. RSI(14) 56, RS Rating 99, -45.0% from its 52-week high, +12.7% year to date. Sector: Healthcare · Pharmaceutical Preparations.
Why INDP moved
From the StockSetups movers recaps that covered INDP, newest first. A recap states what was known that day.
- Close+51.6%
The catalyst here is less clear-cut and worth scrutinizing carefully. The most recent SEC filings — a 424B5 (a prospectus supplement used for a follow-on stock offering, which dilutes existing shareholders) filed September 4 — and a management change 8-K filed the same day are the most recent corporate events.
Top Stock Movers Today — September 8, 2026: Why GCDT, INDP, BNC, ETS & MOBX Surged → - Close+44.7%
No specific August 20 catalyst was found in web research.
Top Stock Movers Today — August 20, 2026: Why BRLS, MMA and INDP Surged →
Trade plan
This setup's entry, stop and target are in Pro.
Free accounts get the full plan on the top 3 setups of every lane.
Financials as of Tue, Jun 30, 2026 · quarterly.
INDP technical analysis
Trend
INDP is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 22.6% above the 50-day ($2.68) and 43.0% above the 200-day ($2.29). The 50-day crossed above the 200-day (a golden cross) 9 sessions ago. ADX(14) at 16 points to a weak trend — more range than direction. It meets 7 of 8 trend-template criteria.
Momentum
RSI(14) is 56, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 99 puts its weighted 12-month performance ahead of about 99% of the US market.
Volume and volatility
Volume on the latest session ran 0.1× its 20-day average. It trades about $971,244 a day on average. ATR(14) is $0.3384, 10.3% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.13) shows accumulation.
Key levels
The chart pattern's support is $3.00 and its resistance $3.52. The 52-week range is $0.9200 to $5.96; price is 45.0% below the high and 256.5% above the low. The VWAP anchored at the 52-week high is $3.08, below price.
Performance
INDP returned -1.5% (1 week), +26.6% (1 month), +162.4% (3 months), +60.0% (6 months), +5.1% (1 year), +12.7% (year to date).
About Indaptus Therapeutics, Inc.
Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.
Pharmaceutical Preparations · Listed 2021 · 5 employees
SEC filings
EDGAR filings in INDP · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.